期刊文献+

靶向抑制表皮生长因子受体对胰腺癌细胞上皮-间质转化的影响及机制 被引量:8

Suppression of epidermal growth factor receptor inhibits epithelial-mesenchymal transition in hu- man pancreatic cancer cells
原文传递
导出
摘要 目的观察靶向抑制表皮生长因子受体(EGFR)对人胰腺癌细胞(PANC-1)上皮-间质转化(EMT)过程的影响,探讨其机制。方法设计并合成针对EGFR基因特异的RNA干扰靶点,运用慢病毒介导的RNA干扰技术沉默人胰腺癌PANC-1细胞EGFR基因表达。应用划痕试验及基质胶侵袭试验检测EGFR干扰后细胞运动、侵袭能力的变化;应用实时定量聚合酶链反应(Real-timePCR)及Westernblot法检测转染后EMT相关标志物E-钙粘蛋白(E-Cadherin)、N-钙粘蛋白(N—Cadherin)、波形蛋白(Vimentin)、纤维粘连蛋白(Fibronectin)等的表达变化,并检测EMT相关转录因子的表达变化;应用细胞免疫荧光共聚焦显微镜检测上述蛋白的定位及细胞形态的变化。结果应用慢病毒介导的RNA干扰技术可特异性抑制人胰腺癌PANC-1细胞EGFR基因的表达。抑制EGFR后PANC-1细胞的运动及侵袭能力显著降低;上皮表型标志物E-Cadherin表达明显上调,间质表型N-Cadherin、Vimentin、Fibronectin等的表达显著下调;与对照组比较,EGFR干扰组细胞由纺锤形变成立方形,伪足消失;EGFR干扰组中EMT相关转录因子Snail及Slug表达显著下调。结论应用慢病毒介导的RNA干扰技术特异性沉默EGFR基因的表达,可显著抑制PANC-1细胞的EMT过程,其机制可能与下调转录因子Snail及Slug表达有关。 Objective To determine the role of epidermal growth factor receptor (EGFR) in mediating epithelial-mesenchymal transition (EMT) in pancreatic cancer cells (PANC-1). Methods PANC-1 cells were transfected with small interfering RNA of EGFR using a lentiviral expression vector to establish an EGFR-knockdown cell line ( si-PANC-1 ). PANC-1 cells transfected with lentiviral vector expressing negative control sequence were used as negative control ( NC-PANC-1 ). Scratch assay and Transwell assay were used to analyze cell migration and invasion. Real-time polymerase chain reaction (PCR) and Western blotting were used to detect the expression of EMT markers E-Cadherin, N-Cadherin, Vimentin, and Fibronectin and transcription factors Snail, Slug, Twistl, and Sipl in PANC-1, NC-PANC-1, and si-PANC-1 cells. hnmunofluorescent staining with the above antibodies and confocal microscopy were applied to observe their cellular location and morphologic changes. Results After RNA interference of EGFR, the migration and invasion ability of si-PANC-1 ceils were decreased significantly. The expression of epithelial phenotype marker E-Cadherin was increased and that of mesenchymal phenotype markers N-Cadherin, Vimenfin, and Fibronectin was decreased, indicating reversion of EMT. The expression of transcription factors Snail and Slug in si-PANC-1 cells was decreased significantly. Conclusion Suppression of EGFR expression can significantly inhibit EMT of pancreatic cancer PANC-1 ceils probably through the down-regulation of the expression of transcription factors Snail and Slug.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第1期13-16,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30972897)
关键词 胰腺癌 表皮生长因子受体 上皮-间质转化 E-CADHERIN Pancreatic carcinoma Epidermal growth factor receptor Epithelial-mesenchymal transition E-Cadherin
  • 相关文献

参考文献9

  • 1Thiery JP, Acloque H, Huang RY, et al. Epithehal-mesenchymal tran- sitions in development and disease. Cell ,2009,139:871-890.
  • 2Hotz B, Arndt M, Dullat S, et al. Epithelial to mesenchymal transition : expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res ,2007 ,13 :4769-4776.
  • 3Ricano JM, Huang M, Barnes LA, et al. Specific cross-talk between ep- idermal growth factor receptor and integrin alphavbeta5 promotes car- cinoma cell invasion and metastasis. Cancer Res, 2009,69: 1383- 1391.
  • 4Thompson CC, Ashcroft FJ, Patel S, et al. Pancreatic cancer cells over- express gelsolin family-capping proteins,which contribute to their cell motility. Gut,2007,56:95-106.
  • 5Wheeler DL, Dunn EF, Harari PM. Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol, 2010.7:493-507.
  • 6朱功兵,赵勤,郭晓枫,王喜艳.抗表皮生长因子受体单克隆抗体对人胰腺癌裸鼠模型的化疗增敏作用[J].中华实验外科杂志,2010,27(10):1489-1491. 被引量:5
  • 7顾劲扬,丁义涛.上皮间质转化在肝脏再生修复中的研究进展[J].中华实验外科杂志,2012,29(5):987-988. 被引量:5
  • 8Carlo A, Prrez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenehymal transitions by repressing E-Cad- herin expression. Nat Cell Biol,2000,2:76-83.
  • 9Wang Z, Li Y, Ahmad A, et al. Pancreatic cancer: understanding and overcoming ehemoresistance. Nat Rev Gastroenterol Hepatol, 2011,8 : 27-33.

二级参考文献11

  • 1康春生,浦佩玉,张志勇,王广秀,贾志凡,裘明哲,原续波,常津.反义表皮生长因子受体RNA对U251胶质瘤细胞生长的抑制作用[J].中华实验外科杂志,2006,23(1):75-77. 被引量:24
  • 2殷涛,王春友,赵刚,刘涛.Snail在胰腺癌中的表达及其与上皮-间叶转化的关系[J].中华实验外科杂志,2006,23(6):695-696. 被引量:16
  • 3杨帆,周足力,姜冠潮,黄宇清,彭洁,王俊.肺癌中表皮生长因子受体过表达与女性、非吸烟、腺癌和基因突变的关系[J].中华实验外科杂志,2007,24(8):973-974. 被引量:12
  • 4Wolff RA.Chemotherapy for pancreatic cancer:from metastatic disease to adjuvant therapy.Cancer J,2007,13:175-184.
  • 5Jimeno A,Rubio-Viqueira B,Amador ML,et al.Dual mitogen-activated protein kinase and epidermal growth factor receptor inhibition in biliary and pancreatic cancer.Mol Cancer Ther,2007,6:1079-1088.
  • 6Reni M,Cordio S,Milandri C,et al.Gemcitabine versus cisplatin,epirubicin,5-fluorouracil,gemcitabine in advanced pancreatic cancer:a phase Ⅲ trial.Lancet Onco1,2005,6:369-376.
  • 7Kimura K,Sawada T,Komatsu M,et al.Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine.Clin Cancer Res,2006,12:4925-4932.
  • 8Rowinsky EK.Targeted induction of apoptosis in cancer management:the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents.J Clin Oncol,2005,23:9394-9407.
  • 9Fesik SW.Promoting apoptosis as a strategy for cancer drug discovery.Nat Rev Cancer,2005,5:876-885.
  • 10Linjawi A,Kontogiannea M,Halwani F,et al.Prognostic significance of p53,bcl-2,and bax expression in early breast cancer.J Am Coll Surg,2004,198:83-90.

共引文献8

同被引文献31

  • 1Apaporn Menakongka,Tuangporn Suthiphongchai.Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion[J].World Journal of Gastroenterology,2010,16(6):713-722. 被引量:33
  • 2Friman S.Cholangiocarcinoma-current treatment options[J].Scand J Surg,2011,100(1):30-34.
  • 3Tsai JH,Yang J.Epithelial-mesenchymal plasticity in carcinoma metastasis[J].Genes Dev,2013,27 (20):2192-2206.
  • 4Bartel DP.MicroRNAs:genomics,biogenesis,mechanism,and function[J].Cell,2004,116(2):281-297.
  • 5Bullock MD,Sayan AE,Packham GK,et al.MicroRNAs:critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression[J].Biol Cell,2012,104(1):3-12.
  • 6Voulgari A,Pintzas A.Epithelial-mesenchymal transition in cancer metastasis:mechanisms,markers and strategies to overcome drug resistance in the clinic[J].Biochim Biophys Acta,2009,1796(2):75-90.
  • 7Bronnum H,Andersen DC,Schneider M,et al.MiR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving programmed cell death 4 and Sprouty-1[J].PLoS One,2013,8(2):e56280.
  • 8Bao L,Yan Y,Xu C,et al.MiR-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways[J].Cancer Lett,2013,337 (2):226-236.
  • 9Wang T,Zhang L,Shi C,et al.TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cells[J].Int J Biochem Cell Biol,2012,44 (2):366-376.
  • 10Siegel R,Naishadham D,Jemal A.Cancer statistics,2012[J].CA Cancer J Clin,2012,62(1):10-29.

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部